UPS invests $48M to upgrade 27 temperature-controlled facilities amid healthcare logistics boom

UPS is investing $48 million to enhance 27 temperature-controlled facilities across the Americas, Europe, and Asia to meet rising demand in healthcare logistics. This upgrade aims to improve the handling of temperature-sensitive medicines like GLP-1 drugs, ensuring faster and safer delivery. The healthcare logistics sector is growing rapidly, driven by the need to maintain strict temperature controls for biologics and vaccines, a market projected to reach $39.1 billion by 2033. UPS sees healthcare as a major growth area, recently achieving a $3 billion healthcare revenue quarter and plans to continue expanding in this space.